This is the introduction to a bonus edition of Checks and Balance, a weekly, subscriber-only newsletter bringing exclusive ...

They are set to vote in a referendum, pushed by the country’s dominant, populist-right SVP party, on whether it should be ...

At a conference in Chicago at the end of May oncologists went wild over the results of a drug called daraxonrasib, which ...

As this article was published the shares had just begun trading at $150, taking the firm’s value to around $2trn—an ...

Cover Story shares preliminary sketches and documents the—often spirited—debates that lead each week to a design seen by millions of people. This week’s cover posed a particular challenge to our ...